CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,303,246 | -35.7% | 566,613 | +2.0% | 0.00% | -100.0% |
| Q2 2023 | $2,026,676 | +4.0% | 555,239 | +1.8% | 0.00% | 0.0% |
| Q1 2023 | $1,947,824 | +149158.5% | 545,624 | +19.2% | 0.00% | – |
| Q4 2022 | $1,305 | -99.9% | 457,667 | +0.8% | 0.00% | – |
| Q3 2022 | $1,013,000 | -39.2% | 454,172 | -32.1% | 0.00% | -100.0% |
| Q2 2022 | $1,666,000 | -54.0% | 668,634 | -9.9% | 0.00% | 0.0% |
| Q1 2022 | $3,620,000 | -62.3% | 741,903 | -12.6% | 0.00% | -66.7% |
| Q4 2021 | $9,606,000 | +257.2% | 849,343 | +360.1% | 0.00% | +200.0% |
| Q3 2021 | $2,689,000 | +186.1% | 184,612 | +128.7% | 0.00% | – |
| Q2 2021 | $940,000 | – | 80,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,840,510 | $5,245,454 | 2.86% |
| P.A.W. CAPITAL CORP | 180,000 | $513,000 | 1.40% |
| Bleichroeder LP | 861,278 | $2,454,642 | 0.53% |
| Monaco Asset Management SAM | 497,177 | $1,416,954 | 0.43% |
| Slate Path Capital LP | 2,402,455 | $6,846,997 | 0.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 306,278 | $872,892 | 0.25% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,363,725 | 0.13% |
| CARLSON CAPITAL L P | 365,000 | $1,040,250 | 0.08% |
| Voss Capital, LLC | 125,000 | $356,250 | 0.07% |
| ADVISORY RESEARCH INC | 257,225 | $733,091 | 0.07% |